Identification of polyamine metabolism-related key genes in allergic rhinitis via bioinformatics analysis and experimental validation
Letters in Drug Design & Discovery · 2026-11 · 100661
DOI: 10.1016/j.lddd.2026.100661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Jinjin Lin und 2 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A substantial body of evidence has established that polyamines play important roles in the pathogenesis of allergic rhinitis (AR). However, the specific contributions of polyamine metabolism-related genes (PMRGs) to AR remain elusive. Therefore, investigating the potential roles of PMRGs in AR may provide further insights into the molecular mechanisms underlying the disease and identify potential biomarkers or therapeutic targets.
Methods
Two datasets, GSE37157 (GPL570) and GSE75011 (GPL16791), were analyzed, and PMRGs were obtained from a publicly available database. Differentially expressed genes (DEGs) were identified and intersected with PMRGs to obtain candidate genes. Functional enrichment and protein–protein interaction (PPI) network analyses were subsequently performed to characterize these genes. Candidate genes were further evaluated through protein classification, tissue-specific expression analysis, regulatory network analysis, and disease and drug association analyses. Finally, quantitative real-time PCR (RT-qPCR) was performed to validate the expression of the candidate genes in AR and control samples.
Results
OAZ2 was identified as a core candidate gene related to polyamine metabolism in AR, while PSME3 was also identified as a candidate gene. Protein classification analysis indicated that OAZ2 was categorized as a regulator of binding activity, while both genes showed relatively stable expression patterns across different tissues. Functional enrichment analysis identified "other glycan degradation" and "proteasome" as the major pathways associated with OAZ2 and PSME3, respectively. Regulatory network analysis predicted 62 transcription factors and 22 miRNAs that may regulate these genes. Disease–gene–drug association analysis identified 84 otolaryngology-related diseases and five potentially associated drugs. RT-qPCR validation demonstrated that OAZ2 was significantly differentially expressed between the AR and control groups, whereas PSME3 did not reach statistical significance and therefore requires further validation.
Conclusion
This study identified OAZ2 as a core polyamine metabolism-related candidate gene in AR, with PSME3 as an additional candidate requiring further validation. The findings provide bioinformatics-based insights into their potential biological and regulatory roles, and may contribute to a better understanding of the molecular mechanisms of AR. OAZ2 may serve as a potential biomarker or therapeutic target, while the role of PSME3 warrants further investigation.
Zitieren
APA
Lin, J., Pan, X., & He, S. (2026). Identification of polyamine metabolism-related key genes in allergic rhinitis via bioinformatics analysis and experimental validation. Letters in Drug Design & Discovery, 100661. https://doi.org/10.1016/j.lddd.2026.100661
Vancouver
Lin J, Pan X, He S. Identification of polyamine metabolism-related key genes in allergic rhinitis via bioinformatics analysis and experimental validation. Letters in Drug Design & Discovery. 2026:100661. doi:10.1016/j.lddd.2026.100661
BibTeX
@article{Lin2026,
author = {Lin, Jinjin and Pan, Xufeng and He, Shan},
title = {Identification of polyamine metabolism-related key genes in allergic rhinitis via bioinformatics analysis and experimental validation},
journal = {Letters in Drug Design & Discovery},
year = {2026},
pages = {100661},
doi = {10.1016/j.lddd.2026.100661}
}
EUVIMED